Výsledky vyhledávání - "Niels-Erik Viby"

Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention

Publikováno v: Hansen, A E, Henriksen, J R, Jølck, R I, Fliedner, F P, Bruun, L M, Scherman, J, Jensen, A I, Munck Af Rosenschöld, P, Moorman, L, Kurbegovic, S, de Blanck, S R, Larsen, K R, Clementsen, P F, Christensen, A N, Clausen, M H, Wang, W, Kempen, P, Christensen, M, Viby, N E, Persson, G, Larsen, R, Conradsen, K, McEvoy, F J, Kjaer, A, Eriksen, T & Andresen, T L 2020, ' Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention ', Science Advances, vol. 6, no. 34, eabb5353 . https://doi.org/10.1126/sciadv.abb5353
Science Advances
Hansen, A E, Henriksen, J R, Jølck, R I, Fliedner, F P, Bruun, L M, Scherman, J, Jensen, A I, Af Rosenschöld, M, Moorman, L, Kurbegovic, S, de Blanck, S R, Larsen, K R, Clementsen, P F, Christensen, A N, Clausen, M H, Wang, W, Kempen, P, Christensen, M, Viby, N E, Persson, G, Larsen, R, Conradsen, K, McEvoy, F J, Kjaer, A, Eriksen, T & Andresen, T L 2020, ' Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention ', Science Advances, vol. 6, no. 34, eabb5353 . https://doi.org/10.1126/sciadv.abb5353

The liquid-based Carbo-gel technology enables real-time multimodal image guidance for improved therapeutic precision.
Diagnostic imaging often outperforms the surgeon’s ability to identify small structures during therapeutic procedures. Smart

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af557bb34715ce6f254598e5ca66ad19
https://orbit.dtu.dk/en/publications/a4fa4a6c-cf48-483e-bef2-18c2788d67d2

Zobrazit plný text záznamu

Trefoil factor peptides in serum and sputum from subjects with asthma and COPD

Autor: Thomas Lund, Steen Seier Poulsen, Niels-Erik Viby, Ebba Nexo, Lars Egholm Pedersen, Vibeke Backer, Hannelouise Kissow, Lars Thim

Publikováno v: The Clinical Respiratory Journal. 9:322-329

Objective Trefoil factor peptides (TFF) are secreted onto mucosal surfaces together with mucins and occur in high concentrations in pulmonary secretions from patients with chronic obstructive pulmonary disease (COPD). In the present study, we aimed t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fb491764146a008b47192e361565076
https://doi.org/10.1111/crj.12146

Zobrazit plný text záznamu

Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine

Autor: Niels-Erik Viby, Jens J. Holst, Bolette Hartmann, Hannelouise Kissow, Lars Thim, Steen Seier Poulsen, Michael Timm

Publikováno v: Cancer Chemotherapy and Pharmacology. 70:39-48

Gastrointestinal mucositis is an unwanted and often dose-limiting side effect to most cancer treatments. Glucagon-like peptide-2 (GLP-2) is a peptide secreted from intestinal L-cells in response to nutrient intake. The peptide is involved in the regu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de595704977428019ccf62be42f6ffc
https://doi.org/10.1007/s00280-012-1882-2

Zobrazit plný text záznamu

Trefoil factors (TFFs) are increased in bronchioalveolar lavage fluid from patients with chronic obstructive lung disease (COPD)

Autor: Helle Andreassen, Steen Seier Poulsen, Niels Erik Viby, Hannelouise Kissow, Lars Thim, Ebba Nexo, Paul Frost Clementsen

Publikováno v: Viby, N-E, Nexø, E, Kissow, H, Andreassen, H, Clementsen, P, Thim, L & Poulsen, S S 2015, ' Trefoil factors (TFFs) are increased in bronchioalveolar lavage fluid from patients with chronic obstructive lung disease (COPD) ', Peptides, vol. 63, pp. 90-95 . https://doi.org/10.1016/j.peptides.2014.09.026

Trefoil factors (TFFs) 1, 2 and 3 are small polypeptides that are co-secreted with mucin throughout the body. They are up-regulated in cancer and inflammatory processes in the gastrointestinal system, where they are proposed to be involved in tissue

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd63d10a2bcdf8d5de26f6dd6877ad4a
https://pubmed.ncbi.nlm.nih.gov/25445610

Zobrazit plný text záznamu

Trefoil factor peptides in serum and sputum from subjects with asthma and COPD

Autor: Niels-Erik, Viby, Lars, Pedersen, Thomas Kromann, Lund, Hannelouise, Kissow, Vibeke, Backer, Ebba, Nexø, Lars, Thim, Steen Seier, Poulsen

Publikováno v: The clinical respiratory journal. 9(3)

Trefoil factor peptides (TFF) are secreted onto mucosal surfaces together with mucins and occur in high concentrations in pulmonary secretions from patients with chronic obstructive pulmonary disease (COPD). In the present study, we aimed to explore

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::95cf9952055c741fd8f5e2f1935065bd
https://pubmed.ncbi.nlm.nih.gov/24720774

Zobrazit plný text záznamu

Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice

Autor: L S Hansen, Niels-Erik Viby, Bolette Hartmann, Mette M. Rosenkilde, Kristine J. Hare, Jens J. Holst, Hannelouise Kissow, Steen Seier Poulsen

Publikováno v: Regulatory peptides. 179(1-3)

Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) are secreted in parallel from the intestinal endocrine cells after nutrient intake. GLP-1 is an incretin hormone and analogues are available for the treatment of type 2 diabetes mell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51fe7569e838d3bc5eb13c9402515898
https://pubmed.ncbi.nlm.nih.gov/22989472

Zobrazit plný text záznamu

The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin

Autor: Bolette Hartmann, Andreas Rosén Rasmussen, Jens J. Holst, Kristine J. Hare, Niels-Erik Viby, Lars Thim, Steen Seier Poulsen

Publikováno v: Digestive diseases and sciences. 55(10)

Erlotinib, an epidermal-growth-factor receptor inhibitor, belongs to a new generation of targeted cancer therapeutics. Gastrointestinal side-effects are common and have been markedly aggravated when erlotinib is combined with cytostatics. We examined

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f201957551963375a3f44aeb09faf74
https://pubmed.ncbi.nlm.nih.gov/20112065

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání